This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Use in a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Keratoacanthomas

Norman Levine, MD; Richard C. Miller, MD; Frank Louis Meyskens, Jr, MD

Arch Dermatol. 1984;120(9):1215-1217.

Abstract
• An 83-year-old woman with multiple squamous cell carcinomas and keratoacanthomas of the legs was treated with orally administered isotretinoin (13 cis-retinoic acid). Complete regression of the tumors was noted during the initial six-month treatment period. In the subsequent 36 months, four new cutaneous tumors were excised. There have been no recurrences of lesions that regressed while the patient was receiving retinoid therapy.

(Arch Dermatol 1984;120:1215-1217)

Author Affiliations
From the Sections of Dermatology (Drs Levine and Miller), Hematology/Oncology, and the Cancer Center (Dr Meyskens), University of Arizona Health Sciences Center, Tucson.

Footnotes
Accepted for publication Aug 23, 1983.

Reprint requests to Section of Dermatology, University of Arizona Health Sciences Center, Tucson, AZ 85724 (Dr Levine).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

All-Trans Retinoic Acid Suppresses Stat3 Signaling during Skin Carcinogenesis
Syed et al.
Cancer Prevention Research 2009;2:903-911.
ABSTRACT | FULL TEXT  

Treatment of Advanced Squamous Cell Carcinoma of the Skin with Isotretinoin
LIPPMAN and MEYSKENS
ANN INTERN MED 1987;107:499-501.
ABSTRACT